Investment Firms in Burlington, North Carolina, United States
Situated in the Piedmont Triad region, it benefits from proximity to major research universities and a historical foundation in textiles and manufacturing, which has evolved into strengths in biotech and advanced materials. The local investment landscape is characterized by a focus on early to mid-stage ventures, particularly within the healthcare and life sciences sectors. This creates a specialized ecosystem that leverages its industrial heritage and academic partnerships to support scalable technology and manufacturing startups.
Burlington, North Carolina, United States's investment landscape is shaped by Biotech & Life Sciences, with 100% of its 1 investment firms focused on this sector. The most active by portfolio size are Labcorp.
Biotech & Life Sciences dominates the investment landscape in Burlington, with 100% of investment firms focused on this sector.
Last updated: 13 March 2026
Investment Firms
1
Total Investments
17
Top Sector
Biotech & Life Sciences
Top Stage
Series B
Top Investment Sectors in Burlington
The most popular sector focus among Burlington investment firms is Biotech & Life Sciences, with 1 investment firm (100%) investing in the space. This is followed by Healthcare (1), Enterprise Software (1), AI (1).
Investment Stages in Burlington
Burlington investment firms are most active at the Series B stage (1 investment firm). This is followed by Series A (1).